Clinical Trials Browser

Phase 1/2 × Advanced Cancer × relatlimab × Clear all

NCT03459222 2026-04-06

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Phase 1/2 Completed

229 enrolled 21 charts

Advanced Cancer